We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Software Platform Receives CE Mark Approval

By MedImaging International staff writers
Posted on 29 May 2018
A broad machine vision and deep-learning software platform, which supports the assessment of multiple clinical indications, including the detection of intracranial hemorrhage (ICH), has received the CE Mark approval. The software platform named Accipio has been developed by MaxQ Artificial Intelligence (Andover, MA, USA), a global artificial intelligence (AI) healthcare company focusing on empowering confident, life-saving decision support through AI-enabled tools at the point of care.

Accurate and timely detection of ICH, commonly known as a brain bleed, is a critical step in clinical decision-making for stroke assessment and head trauma. AccipioIx, the first of multiple Accipio versions, is based on deep-learning technologies, which automatically analyzes non-contrast head computed tomography (CT) images. The AI AccipioIx algorithm is highly sensitive to the presence of ICH, identifying and prioritizing patients with ICH for the physician treating the patient. It provides a case-level signal, allowing rapid triage and prioritization of the patient and can be natively integrated into PACS systems, medical imaging hardware, or healthcare clouds. AccipioIx is now approved for commercial sale within the European Union.

"We are delighted to receive the CE Mark for AccipioIx, the first of many global regulatory approvals," said Gene Saragnese, Chairman and CEO of MaxQ-AI. "At MaxQ-AI we are developing a suite of advanced clinical decision support and workflow tools for acute healthcare physicians and their patients on a global basis. Designed to provide actionable insights, our platform leverages the power of AI, combined with the skill of the physician, leading to better patient outcomes and improved healthcare economics."

Related Links:
MaxQ Artificial Intelligence

X-Ray Illuminator
X-Ray Viewbox Illuminators
Pocket Fetal Doppler
CONTEC10C/CL
Portable X-ray Unit
AJEX140H
X-ray Diagnostic System
FDX Visionary-A

Channels

Ultrasound

view channel
Image: The new implantable device for chronic pain management is small and flexible (Photo courtesy of The Zhou Lab at USC)

Wireless Chronic Pain Management Device to Reduce Need for Painkillers and Surgery

Chronic pain affects millions of people globally, often leading to long-term disability and dependence on opioid medications, which carry significant risks of side effects and addiction.... Read more

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.